Preventive effects of 23-valent pneumococcal polysaccharide vaccine on community-acquired pneumonia hospitalization in older individuals in China: A case-control study

The effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPSV23) against hospitalization risk due to all-cause community-acquired pneumonia (CAP) in older individuals in China is limited. A hospital-based case-control study was conducted on this issue in Suzhou City, Jiangsu Province, Chi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Na Liu, Lei Wang, Lin Luan, Huaqing Wang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis Group 2024-12-01
סדרה:	Human Vaccines & Immunotherapeutics
נושאים:	23-valent pneumococcal polysaccharide vaccine vaccine effectiveness community-acquired pneumonia hospitalization risk older individuals
גישה מקוונת:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2420450
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!